Hester AG, et al. – Purpose of this study was to demonstrate the recent advances in the oral treatments for overactive bladder in the pediatric population. It was illustrated that children with overactive bladder are now served with more therapeutic options than previously available. Moreover, anticholinergics alone or in combination with medications such as mirabegron or alpha–blockers enhance bladder capacity and rates of dryness in these children. Future study is underway to further improve the drugs at hand while reducing their side effect profiles.